(Q44414984)

2 December 2017

Prostacyclin/thromboxane early changes in pregnancies that are complicated by preeclampsia (English)

1 reference

2 December 2017

0 references

María Eugenia Chavarría

1

1 reference

2 December 2017

Lina Lara-González

2

1 reference

2 December 2017

Alejandro González-Gleason

3

1 reference

2 December 2017

Yolanda García-Paleta

4

1 reference

2 December 2017

Víctor Saúl Vital-Reyes

5

1 reference

2 December 2017

Alejandro Reyes

6

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

full work available at URL

2 December 2017

https://api.elsevier.com/content/article/PII:S0002937802715238?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1067/MOB.2003.203

https://api.elsevier.com/content/article/PII:S0002937802715238?httpAccept=text/plain

27 December 2023

1 reference

https://api.crossref.org/works/10.1067/MOB.2003.203

American Journal of Obstetrics and Gynecology

27 December 2023

published in

1 reference

2 December 2017

188

1 reference

2 December 2017

4

1 reference

2 December 2017

986-992

1 reference

Etiology and pathogenesis of preeclampsia: current concepts

2 December 2017

https://api.crossref.org/works/10.1067/MOB.2003.203

1

1 reference

Prostaglandin H synthase and vascular function

27 December 2023

https://api.crossref.org/works/10.1067/MOB.2003.203

2

1 reference

Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction

27 December 2023

https://api.crossref.org/works/10.1067/MOB.2003.203

3

1 reference

Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study

27 December 2023

https://api.crossref.org/works/10.1067/MOB.2003.203

4

1 reference

Plasma prostacyclin and thromboxane concentrations in 160 normotensive, hypotensive, and preeclamptic patients during pregnancy, delivery, and the post partum period

27 December 2023

https://api.crossref.org/works/10.1067/MOB.2003.203

5

1 reference

Vasoactive mediators in pregnancy-induced hypertensive disorders: a longitudinal study

27 December 2023

https://api.crossref.org/works/10.1067/MOB.2003.203

6

1 reference

Do prostacyclin and thromboxane contribute to the "protective effect" of pregnancies with chronic hypertension? A preliminary prospective longitudinal study

27 December 2023

https://api.crossref.org/works/10.1067/MOB.2003.203

7

1 reference

Hypertensive and normal pregnancy: a longitudinal study of blood pressure, distensibility of dorsal hand veins and the ratio of the stable metabolites of thromboxane A2 and prostacyclin in plasma

27 December 2023

https://api.crossref.org/works/10.1067/MOB.2003.203

8

1 reference

The role of aggregation of platelets in pregnancy-induced hypertension: a comprehensive and longitudinal study

27 December 2023

https://api.crossref.org/works/10.1067/MOB.2003.203

9

1 reference

Maternal levels of prostacyclin, thromboxane, vitamin E, and lipid peroxides throughout normal pregnancy

27 December 2023

https://api.crossref.org/works/10.1067/MOB.2003.203

10

1 reference

Prostacyclin versus thromboxane metabolite excretion: changes in pregnancy and labor

27 December 2023

https://api.crossref.org/works/10.1067/MOB.2003.203

11

1 reference

Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension

27 December 2023

https://api.crossref.org/works/10.1067/MOB.2003.203

12

1 reference

Renal prostacyclin and thromboxane in normotensive and preeclamptic pregnant women and their infants

27 December 2023

https://api.crossref.org/works/10.1067/MOB.2003.203

13

1 reference

Immunoreactive prostacyclin and thromboxane metabolites in normal pregnancy and the puerperium

27 December 2023

https://api.crossref.org/works/10.1067/MOB.2003.203

14

1 reference

6-Keto prostaglandin F1 alpha, thromboxane B2, and 13,14-dihydro-15-keto prostaglandin F concentrations of normotensive and preeclamptic patients during pregnancy, delivery, and the postpartum period

27 December 2023

https://api.crossref.org/works/10.1067/MOB.2003.203

15

1 reference

Prostacyclin production during pregnancy: comparison of production during normal pregnancy and pregnancy complicated by hypertension

27 December 2023

https://api.crossref.org/works/10.1067/MOB.2003.203

16

1 reference

Thromboxane A2 in pregnancy and puerperium

27 December 2023

https://api.crossref.org/works/10.1067/MOB.2003.203

17

1 reference

Maternal plasma cellular fibronectin concentrations in normal and preeclamptic pregnancies: a longitudinal study for early prediction of preeclampsia

27 December 2023

https://api.crossref.org/works/10.1067/MOB.2003.203

18

1 reference

ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002.

27 December 2023

https://api.crossref.org/works/10.1067/MOB.2003.203

19

1 reference

The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood

27 December 2023

https://api.crossref.org/works/10.1067/MOB.2003.203

21

1 reference

Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways

27 December 2023

https://api.crossref.org/works/10.1067/MOB.2003.203

24

1 reference

Total plasma fibronectin as a marker of pregnancy-induced hypertensive disorders: a longitudinal study

27 December 2023

https://api.crossref.org/works/10.1067/MOB.2003.203

25

1 reference

27 December 2023

Identifiers

DOI

10.1067/MOB.2003.203

1 reference

2 December 2017

1 reference